Correlation Between MaxCyte and Tela Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MaxCyte and Tela Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MaxCyte and Tela Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MaxCyte and Tela Bio, you can compare the effects of market volatilities on MaxCyte and Tela Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MaxCyte with a short position of Tela Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of MaxCyte and Tela Bio.

Diversification Opportunities for MaxCyte and Tela Bio

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between MaxCyte and Tela is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and Tela Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tela Bio and MaxCyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MaxCyte are associated (or correlated) with Tela Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tela Bio has no effect on the direction of MaxCyte i.e., MaxCyte and Tela Bio go up and down completely randomly.

Pair Corralation between MaxCyte and Tela Bio

Given the investment horizon of 90 days MaxCyte is expected to under-perform the Tela Bio. But the stock apears to be less risky and, when comparing its historical volatility, MaxCyte is 1.21 times less risky than Tela Bio. The stock trades about -0.41 of its potential returns per unit of risk. The Tela Bio is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  267.00  in Tela Bio on November 28, 2024 and sell it today you would lose (7.00) from holding Tela Bio or give up 2.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MaxCyte  vs.  Tela Bio

 Performance 
       Timeline  
MaxCyte 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in MaxCyte are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, MaxCyte may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Tela Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tela Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

MaxCyte and Tela Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MaxCyte and Tela Bio

The main advantage of trading using opposite MaxCyte and Tela Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MaxCyte position performs unexpectedly, Tela Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tela Bio will offset losses from the drop in Tela Bio's long position.
The idea behind MaxCyte and Tela Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios